Anyone here transition from healthcare marketing into device sales? I’ve led positioning and customer engagement for a cardiac launch and used a 3-touch sequence to open 12 IDN accounts in Q2; how did you frame similar wins so hiring managers saw territory growth potential and clinician credibility, not just marketing polish?
Frame it as a territory case study: I translated ‘opened 12 IDNs’ into pipeline math (targets→meetings→demos→first POs) and closed with a 30–60-90 for three named systems plus one clinician quote to show credibility, not polish. Do you have a KOL willing to be a two-line reference?
Translate your 3-touch into ‘VAC-approved in 30 days’ plus surgeon quote; did Q2’s 12 IDNs yield first POs?
What worked for me was converting the 3-touch into clinician-facing proof: “Q2: 6 cath labs trained, 4 inservices booked, 22 hours of case support, loaner set placed,” then tying that to weekly usage via those labs’ DRG volumes so it reads as territory lift, not campaign polish. If you don’t have case hours yet, swap in “credentialed in 12 days” and “proctor scheduled” to signal clinician trust. Do you have a clinical educator from that cardiac launch who’ll vouch for your “time-to-case”?
Piggybacking on @vmayers84, show “less sizzle, more steak” with a one-pager: territory map by stage, next actions, and committee dates, plus a clinical line like “5 cases observed, 1 proctored, scrub team vouches” so they see you can run a route and be in the room, not just build decks; want the template I use?
Quick example: I turned a cardiac launch into a sales signal by tracking ‘time-to-first case’ and ‘days-to-reorder’ per target, then brought a simple log of case coverage and objections to show I wasn’t just brand polish… If your Q2 work was heavy with IDNs, frame it as X moved from education to first case in Y days with one surgeon quote tied to outcome; if you don’t have reorder yet, use scheduled case dates or committee agendas. What was your average days from intro to first case?
I’d translate your “12 IDNs in Q2” into an access-to-revenue story: show vendor master added, committee date locked, eval window, and a rough ASP x volume so a manager sees a 30–90 day ramp, not just activity… Small caveat: if NDA blocks specifics, use ranges and a % conversion from eval to standard. Do you have those committee dates and ASP assumptions handy?
I’d package it as a 90-day territory hypothesis — two service lines to prioritize, the call plan by buying center, and a simple stat like “8 targeted sites → 5 evals → 3 conversions” you’ve replicated. Add one clinician verbatim for credibility (“EP chief: ‘we kept it after trial’”) plus a small before/after on cycle time you shortened, then ask to pressure-test it against their map; @vmayers84 has the steak, your edge is showing repeatability across regions — do you have two markets where that outreach cadence held up?
Turn your “3-touch sequence” into a clinic-facing proof pack: one-pager per IDN showing who sponsored you clinically, the in-service you ran, and that you’re on the preference card or have RepTrax/Vendormate cleared — , managers skim, so keep it scannable. I did this and bolded two short clinician quotes plus next month’s scheduled in-services, so it read like pipeline, not marketing. If you’re light on proof, map each IDN with a simple MEDDICC snapshot: https://www.meddicc.com/ — does that fit your 12 IDNs in Q2?